ALLIANCE PHARMACEUTICAL CORP
S-3, EX-23.(B), 2000-09-29
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ALLIANCE PHARMACEUTICAL CORP, S-3, EX-5, 2000-09-29
Next: CUISINE SOLUTIONS INC, NTN 10K, 2000-09-29





<PAGE>


                                                                Exhibit 23.(b)

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Alliance
Pharmaceutical Corp. for the registration of shares of its common stock and to
the incorporation by reference therein of our report dated August 1, 2000, with
respect to the consolidated financial statements of Alliance Pharmaceutical
Corp. included in its Annual Report on Form 10-K for the year ended June 30,
2000, filed with the Securities and Exchange Commission.



                                                         /s/ ERNST & YOUNG LLP


San Diego, California
September 29, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission